Showing results (1-10 of 164) with videos related to
Sort By:
Pageof 17
Environmental Science & Technology|July 25, 2013
Quantifying the trade-off between parameter and model structure uncertainty in life cycle impact assessmentRosalie van Zelm, Mark A J HuijbregtsEnvironmental Toxicology and Chemistry|August 25, 2005
Calculating life-cycle assessment effect factors from potentially affected fraction-based ecotoxicological response functionsDik van de Meent, Mark A J HuijbregtsThe Science of the Total Environment|August 30, 2008
Cadmium bioaccumulation factors for terrestrial species: application of the mechanistic bioaccumulation model OMEGA to explain field dataKarin Veltman, Mark A J Huijbregts, A Jan HendriksEnvironmental Pollution (Barking, Essex : 1987)|February 4, 2016
Valuing the human health damage caused by the fraud of VolkswagenRik Oldenkamp, Rosalie van Zelm, Mark A J HuijbregtsChemosphere|August 31, 2007
A new twist on an old regression: transfer of chemicals to beef and milk in human and ecological risk assessmentA Jan Hendriks, Hana Smítková, Mark A J HuijbregtsEnvironmental Science & Technology|June 3, 2010
Integration of biotic ligand models (BLM) and bioaccumulation kinetics into a mechanistic framework for metal uptake in aquatic organismsKarin Veltman, Mark A J Huijbregts, A Jan HendriksNature Protocols|July 9, 2025
Performing life cycle impact assessment with the midpoint and endpoint method ReCiPeRosalie van Zelm, Thomas Hennequin, Mark A J HuijbregtsEnvironment International|May 19, 2007
PestScreen: a screening approach for scoring and ranking pesticides by their environmental and toxicological concernRonnie Juraske, Assumpció Antón, Francesc Castells, et al.Critical Reviews in Toxicology|December 10, 2015
Uncertainty and variability in human exposure limits - a chemical-specific approach for ciprofloxacin and methotrexateRik Oldenkamp, Mark A J Huijbregts, Ad M J RagasEnvironment International|March 22, 2016
The influence of uncertainty and location-specific conditions on the environmental prioritisation of human pharmaceuticals in EuropeRik Oldenkamp, Mark A J Huijbregts, Ad M J RagasPageof 17